Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice

World Journal of Gastroenterology

Volumn 20, Issue 45, 2014, Pages 17084-17091

  Kim, Mi Na ^a   Koh, Seong Joon ^b   Kim, Jung Mogg ^c   Im, Jong Pil ^d   Jung, Hyun Chae ^d   Kim, Joo Sung ^d  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Hanyang University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Clostridium difficile; Colitis; Inflammatory bowel disease; Interleukin 10 deficient mice; Interferon

Indexed keywords

CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; BACTERIAL TOXIN; ENTEROTOXIN; IL10 PROTEIN, MOUSE; MESSENGER RNA; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL STIMULATION; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLONY FORMATION; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATORY BOWEL DISEASE; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COLON; DEFICIENCY; DENDRITIC CELL; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PSEUDOMEMBRANOUS COLITIS; SEVERITY OF ILLNESS INDEX; TIME;

ANIMALS; BACTERIAL TOXINS; BONE MARROW CELLS; CELLS, CULTURED; CLOSTRIDIUM DIFFICILE; COLITIS; COLON; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-23; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WEIGHT LOSS;

EID: 84917706337     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i45.17084     Document Type: Article

References (41)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434 [PMID: 17653185 DOI: 10.1038/nature06005]
2. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-1728 [PMID: 21530738 DOI: 10.1053/j.gastro.2011.01.054]
3. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-Associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298: 531-534 [PMID: 625309 DOI: 10.1056/nejm197803092981003]
4. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346-353 [PMID: 11774082 DOI: 10.1086/338260]
5. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998; 49: 375-390 [PMID: 9509270 DOI: 10.1146/annurev. med.49.1.375]
6. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262 [PMID: 8043060 DOI: 10.1056/nejm199401273300406]
7. Sun X, Savidge T, Feng H. The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) 2010; 2: 1848-1880 [PMID: 22069662 DOI: 10.3390/toxins2071848]
8. Mann EA, Saeed SA. Gastrointestinal infection as a trigger for inflammatory bowel disease. Curr Opin Gastroenterol 2012; 28: 24-29 [PMID: 22080823 DOI: 10.1097/ MOG.0b013e32834c453e]
9. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57: 205-210 [PMID: 17905821 DOI: 10.1136/gut.2007.128231]
10. Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol 2010; 16: 4892-4904 [PMID: 20954275]
11. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 1432-1442 [PMID: 18484669 DOI: 10.1002/ibd.20500]
12. Fekety R, Silva J, Toshniwal R, Allo M, Armstrong J, Browne R, Ebright J, Rifkin G. Antibiotic-Associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis 1979; 1: 386-397 [PMID: 549190]
13. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8: 564-577 [PMID: 20622892 DOI: 10.1038/nrmicro2403]
14. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP. A mouse model of Clostridium difficile-Associated disease. Gastroenterology 2008; 135: 1984-1992 [PMID: 18848941 DOI: 10.1053/ j.gastro.2008.09.002]
15. Kang SJ, Kim JM, Koh SJ, Kim SH, Im JP, Jung HC, Kim JS. The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice. Life Sci 2013; 92: 1064-1071 [PMID: 23603141 DOI: 10.1016/j.lfs.2013.04.003]
16. Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005; 115: 375-387 [PMID: 15946255 DOI: 10.1111/ j.1365-2567.2005.02156.x]
17. Kelly CP, Becker S, Linevsky JK, Joshi MA, OKeane JC, Dickey BF, LaMont JT, Pothoulakis C. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 1994; 93: 1257-1265 [PMID: 7907603 DOI: 10.1172/jci117080]
18. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594 [PMID: 18242222 DOI: 10.1053/j.gastro.2007.11.059]
19. Uhlig HH, Powrie F. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Eur J Immunol 2009; 39: 2021-2026 [PMID: 19672896 DOI: 10.1002/eji.200939602]
20. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66: 5224-5231 [PMID: 9784526]
21. Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996; 98: 1010-1020 [PMID: 8770874 DOI: 10.1172/jci118861]
22. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274 [PMID: 8402911]
23. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S, Lynch RG. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002; 123: 1527-1542 [PMID: 12404228]
24. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756-1767 [PMID: 21530742 DOI: 10.1053/ j.gastro.2011.02.016]
25. Buonomo EL, Madan R, Pramoonjago P, Li L, Okusa MD, Petri WA. Role of interleukin 23 signaling in Clostridium difficile colitis. J Infect Dis 2013; 208: 917-920 [PMID: 23776194 DOI: 10.1093/infdis/jit277]
26. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 1998; 161: 3143-3149 [PMID: 9743382]
27. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310-1316 [PMID: 16670770 DOI: 10.1172/jci21404]
28. Ishida Y, Maegawa T, Kondo T, Kimura A, Iwakura Y, Nakamura S, Mukaida N. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. J Immunol 2004; 172: 3018-3025 [PMID: 14978106]
29. Kurihara Y, Furue M. Interferon-γ enhances phorbol myristate acetate-induced cell attachment and tumor necrosis factor production via the NF-κB pathway in THP-1 human monocytic cells. Mol Med Rep 2013; 7: 1739-1744 [PMID: 23589028 DOI: 10.3892/mmr.2013.1419]
30. Pourshafie MR, Sonnenfeld G. Treatment of an infected murine macrophage cell line (J774A.1) with interferon-gamma but not tumor necrosis factor-Alpha or live Mycobacterium intracellulare alone modulates the expression of adhesion molecules. J Interferon Cytokine Res 1997; 17: 69-75 [PMID: 9058312]
31. Tong Q, Vassilieva EV, Ivanov AI, Wang Z, Brown GT, Parkos CA, Nusrat A. Interferon-gamma inhibits T84 epithelial cell migration by redirecting transcytosis of beta1 integrin from the migrating leading edge. J Immunol 2005; 175: 4030-4038 [PMID: 16148152]
32. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA, Nusrat A. Mechanism of IFN-gammainduced endocytosis of tight junction proteins: myosin IIdependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005; 16: 5040-5052 [PMID: 16055505 DOI: 10.1091/mbc.E05-03-0193]
33. Günzel D, Florian P, Richter JF, Troeger H, Schulzke JD, Fromm M, Gitter AH. Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1496-R1507 [PMID: 16397094 DOI: 10.1152/ajpregu.00470.2005]
34. Adams RB, Planchon SM, Roche JK. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993; 150: 2356-2363 [PMID: 8450217]
35. Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 2004; 127: 300-309 [PMID: 15236195]
36. Niess JH, Reinecker HC. Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract. Curr Opin Gastroenterol 2005; 21: 687-691 [PMID: 16220046]
37. Ausiello CM, Cerquetti M, Fedele G, Spensieri F, Palazzo R, Nasso M, Frezza S, Mastrantonio P. Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells. Microbes Infect 2006; 8: 2640-2646 [PMID: 16935543 DOI: 10.1016/j.micinf.2006.07.009]
38. Lee JY, Kim H, Cha MY, Park HG, Kim YJ, Kim IY, Kim JM. Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway. J Mol Med (Berl) 2009; 87: 169-180 [PMID: 18985311 DOI: 10.1007/ s00109-008-0415-2]
39. Smith CL, Geier MS, Yazbeck R, Torres DM, Butler RN, Howarth GS. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer 2008; 60: 757-767 [PMID: 19005975 DOI: 10.1080/01635580802192841]
40. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8: e1002995 [PMID: 23133377 DOI: 10.1371/journal. ppat.1002995]
41. Yun B, Oh S, Griffiths MW. Lactobacillus acidophilus modulates the virulence of Clostridium difficile. J Dairy Sci 2014; 97: 4745-4758 [PMID: 24856984 DOI: 10.3168/jds.2014-7921]